Identifying novel breast cancer subtypes effect on clinical response to neoadjuvant chemotherapy

被引:0
|
作者
Bhatt, N. [1 ]
Fiuza-Castinieria, C. [1 ]
Murphy, S. [1 ]
O'Connor, M. [1 ]
O'Donoghue, G. T. [1 ]
机构
[1] Waterford Reg Hosp, Waterford, Ireland
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:22 / 22
页数:1
相关论文
共 50 条
  • [21] Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer
    Kim, Seung Il
    Sohn, Joohyuk
    Koo, Ja Seung
    Park, Se Ho
    Park, Hyung Seok
    Park, Byeong Woo
    ONCOLOGY, 2010, 79 (5-6) : 324 - 330
  • [22] Subtypes of invasive breast carcinoma and pathologic response to neoadjuvant chemotherapy
    Peiro, G.
    Aranda, F. I.
    Adrover, E.
    Planelles, M.
    Alenda, C.
    Paya, A.
    Segui, J.
    LABORATORY INVESTIGATION, 2007, 87 : 44A - 45A
  • [23] Subtypes of invasive breast carcinoma and parthologic response to neoadjuvant chemotherapy
    Peiro, G.
    Aranda, F. I.
    Adrover, E.
    Planelles, M.
    Alenda, C.
    Paya, A.
    Segui, J.
    MODERN PATHOLOGY, 2007, 20 : 44A - 45A
  • [24] Race, response to chemotherapy, and outcome within clinical breast cancer subtypes
    Tichy, J. R.
    Deal, A. M.
    Anders, C. K.
    Reeder-Hayes, K.
    Carey, L. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) : 667 - 674
  • [25] Race, response to chemotherapy, and outcome within clinical breast cancer subtypes
    J. R. Tichy
    A. M. Deal
    C. K. Anders
    K. Reeder-Hayes
    L. A. Carey
    Breast Cancer Research and Treatment, 2015, 150 : 667 - 674
  • [26] Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer
    Bhumsuk Keam
    Seock-Ah Im
    Yoojoo Lim
    Sae-Won Han
    Hyeong-Gon Moon
    Do-Youn Oh
    Nariya Cho
    Se-Hoon Lee
    Wonshik Han
    Woo Kyung Moon
    Dong-Wan Kim
    Tae-You Kim
    In Ae Park
    Dong-Young Noh
    Annals of Surgical Oncology, 2013, 20 : 2242 - 2249
  • [27] Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer
    Keam, Bhumsuk
    Im, Seock-Ah
    Lim, Yoojoo
    Han, Sae-Won
    Moon, Hyeong-Gon
    Oh, Do-Youn
    Cho, Nariya
    Lee, Se-Hoon
    Han, Wonshik
    Moon, Woo Kyung
    Kim, Dong-Wan
    Kim, Tae-You
    Park, In Ae
    Noh, Dong-Young
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2242 - 2249
  • [28] Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer
    Seber, Erdogan Selcuk
    Iriagac, Yakup
    Cavdar, Eyyup
    Karaboyun, Kubilay
    Avci, Okan
    Yolcu, Ahmet
    Gurdal, Sibel Ozkan
    Oznur, Meltem
    Ekinci, Ferhat
    Aytac, Ali
    Gulturk, Ilkay
    Yilmaz, Mesut
    Sever, Nadiye
    Kapagan, Tanju
    Ferhatoglu, Ferhat
    Kahvecioglu, Fatma Akdag
    Hacibekiroglu, Ilhan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (01): : 37 - 41
  • [29] Molecular subtypes in patients with breast cancer that received neoadjuvant chemotherapy
    Marta, G.
    Mano, M.
    Oliveira, L.
    Pereira, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S504 - S504
  • [30] Identifying dihydrofolate reductase as a predictor for poor response to neoadjuvant chemotherapy in breast cancer patients
    Shi, Tingting
    Tian, Nannan
    Wu, Yueting
    Xu, Lin
    Sun, Weijuan
    Wang, Qiang
    Zhang, Mei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (12): : 13619 - 13626